A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors - Concepedia

Concepedia

Publication | Open Access

A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors

DOI Full Paper Access

71

Citations

36

References

2022

Year

Stephen L. Chan, Martin Schüler, Yoon‐Koo Kang, Chia‐Jui Yen, Julien Edeline, Su Pin Choo, Chia‐Chi Lin, Takuji Okusaka, Karl-Heinz Weiss, Teresa Macarulla,

Journal of Experimental & Clinical Cancer Research

References

	Year	Citations

Page 1